Joanna Jakobkiewicz-Banecka
Overview
Explore the profile of Joanna Jakobkiewicz-Banecka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
1005
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lica J, Jakobkiewicz-Banecka J, Hellmann A
Front Cell Dev Biol
. 2025 Jan;
12():1463807.
PMID: 39830209
Recent experimental findings indicate that cancer stem cells originate from transformed very small embryonic-like stem cells. This finding represents an essential advancement in uncovering the processes that drive the onset...
2.
Lica J, Pradhan B, Safi K, Jakobkiewicz-Banecka J, Hellmann A
Molecules
. 2024 Sep;
29(17).
PMID: 39275127
In this review we explore innovative approaches in the treatment of hematologic cancers by combining various therapeutic modalities. We discuss the synergistic potential of combining inhibitors targeting different cellular pathways...
3.
Sledzinska K, Kloska A, Jakobkiewicz-Banecka J, Landowski P, Oppmann A, Wilczynski S, et al.
Nutrients
. 2024 Jul;
16(14).
PMID: 39064704
The etiopathogenesis of inflammatory bowel disease (IBD) is still unclear. Prior studies suggest genetic components that may influence the incidence and severity of the disease. Additionally, it was shown that...
4.
Malinowska M, Nowicka W, Kloska A, Wegrzyn G, Jakobkiewicz-Banecka J
Int J Mol Sci
. 2024 Feb;
25(4).
PMID: 38397051
Mucopolysaccharidosis type I (MPS I) is a lysosomal storage disorder caused by α-L-iduronidase deficiency. The standard treatment, enzyme replacement therapy with laronidase, has limited effectiveness in treating neurological symptoms due...
5.
Lica J, Gucwa K, Heldt M, Stupak A, Maciejewska N, Ptaszynska N, et al.
Molecules
. 2024 Feb;
29(3).
PMID: 38338422
The fusion of penetrating peptides (PPs), e.g., cell penetration peptides (CPPs) or antimicrobial peptides (AMPs), together with antimicrobial agents is an expanding research field. Specific AMPs, such as lactoferricin B...
6.
Zielinski K, Pukszta S, Mickiewicz M, Kotlarz M, Wygocki P, Zielen M, et al.
PLoS Comput Biol
. 2023 Apr;
19(4):e1011020.
PMID: 37104276
Controlled ovarian stimulation is tailored to the patient based on clinical parameters but estimating the number of retrieved metaphase II (MII) oocytes is a challenge. Here, we have developed a...
7.
Juchniewicz P, Kloska A, Portalska K, Jakobkiewicz-Banecka J, Wegrzyn G, Liss J, et al.
Chromosome Res
. 2023 Jan;
31(1):4.
PMID: 36695960
Female somatic X-chromosome inactivation (XCI) balances the X-linked transcriptional dosages between the sexes, randomly silencing the maternal or paternal X chromosome in each cell of 46,XX females. Skewed XCI toward...
8.
Wesierska M, Nowicka W, Kloska A, Jakobkiewicz-Banecka J, Malinowska M
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613977
Mucopolysaccharidosis type I (MPS I) is a metabolic genetic disease caused by the deficiency of a lysosomal enzyme involved in glycosaminoglycans (GAGs) degradation. MPS I cells have a constant level...
9.
Wesierska M, Kloska A, Medina D, Jakobkiewicz-Banecka J, Gabig-Ciminska M, Radzinska M, et al.
Int J Mol Sci
. 2022 Feb;
23(3).
PMID: 35162981
Flavonoids are investigated as therapeutics for mucopolysaccharidosis, a metabolic disorder with impaired glycosaminoglycan degradation. Here we determined the effects of genistein and kaempferol, used alone or in combination, on cellular...
10.
Bochenska K, Moskot M, Smolinska-Fijolek E, Jakobkiewicz-Banecka J, Szczerkowska-Dobosz A, Slominski B, et al.
Sci Rep
. 2021 Sep;
11(1):18297.
PMID: 34521933
Genistein is applied worldwide as an alternative medicament for psoriasis (Ps) because of its anti-inflammatory activity and perceived beneficial impact on the skin. Hereby, we report our in vivo and...